Europe
The Goal Is To Develop Novel Pre-clinical Programmes For High Unmet Medical Need Conditions For Women
Companies strengthen their leadership teams and boards of directors with these appointments.
The U.K. government is working to ensure adequate quantities of medications and medical devices are on hand for the transition period that will follow any form of Brexit. As for the life sciences and biotech industries – it’s become increasingly clear they face acute disruption as a result of this period of uncertainty.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at the University of Strathclyde have potentially developed a blood test for brain cancer using high-throughput attenuated total reflection (ATR)-Fourier transform infrared (FTIR) spectroscopy with machine learning.
UCB indicates the deal is part of its strategic growth plan, dubbed the “Accelerate and Expand” phase since 2019.
N-SIDE, a global software consulting company specializing in advanced analytics technologies, is pleased to welcome Wade Wirta as US Managing Director.
Helsinn announces it will be co-hosting alongside Recordati Rare Diseases, a worldwide leader in rare diseases and orphan drugs, part of Recordati Group, a satellite symposium at the 28th European Academy of Dermatology and Venereology Congress, held this year in Madrid from 9 – 13 October 2019.
Rentschler Biopharma SE, a world-class contract development and manufacturing organization for biopharmaceuticals, has been featured on the annual list of Germany’s best employers for the second year in a row.
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.
PRESS RELEASES